Yipeng Liu | Nephrology | Young Scientist Award

Prof. Yipeng Liu | Nephrology | Young Scientist Award

The First Affiliated Hospital of Shandong First Medical University | China

Author Profile

Scopus

YIPENG LIU: A PIONEER IN NEPHROLOGY RESEARCH ⚕️

EARLY ACADEMIC PURSUITS 🎓

Born in October 1985, Dr. Yipeng Liu demonstrated an early aptitude for medicine. He pursued his medical education with dedication, ultimately earning a medical doctorate. His academic training laid the foundation for a distinguished career in nephrology, focusing on podocytopathies. With a keen interest in clinical and basic research, he gained extensive expertise in idiopathic membranous nephropathy. His strong academic background enabled him to make significant contributions to both research and clinical practice.

PROFESSIONAL ENDEAVORS 🌟

Dr. Liu holds the prestigious position of Chief Physician in the Nephrology Department at Shandong Provincial Qianfoshan Hospital. He is also a Professor, Research Fellow, and PhD Supervisor. His leadership roles extend to serving as the Deputy Director of the Shandong Kidney Disease Research Institute. Recognized as a Taishan Scholar Young Expert for two consecutive terms (2019 and 2025), Dr. Liu has played a crucial role in advancing nephrology research. His professional memberships in leading medical associations reflect his influence in the field.

CONTRIBUTIONS AND RESEARCH FOCUS ON NEPHROLOGY🔬

Dr. Liu’s research is centered on podocytopathies in nephrology, with a specialized focus on idiopathic membranous nephropathy. He made a groundbreaking contribution by proposing the optimal diagnostic cutoff value for anti-PLA2R antibodies in Chinese patients, revolutionizing the non-invasive diagnosis of the disease. Additionally, he identified the risk factors and pathogenic links of thrombotic events in idiopathic membranous nephropathy, which provided essential insights for targeted anticoagulation therapy. His work on serum predictive factors has also significantly improved prognostic assessments in nephrology.

IMPACT AND INFLUENCE ✨

Dr. Liu’s research has shaped nephrology diagnostics and treatment protocols. His findings on anti-PLA2R antibody thresholds have influenced clinical guidelines, improving non-invasive diagnostic strategies worldwide. His insights into thrombotic risks in membranous nephropathy have set the foundation for safer and more effective treatment protocols. He actively collaborates with leading researchers on multicenter observational studies, expanding his influence in global nephrology research.

ACADEMIC CITATIONS 📖

Dr. Liu’s extensive research has been recognized in numerous indexed journals. His published works have a high citation index in databases such as SCI and Scopus, reflecting his contributions to medical science. His collaborative work on primary membranous nephropathy continues to receive significant academic attention, reinforcing his role as a thought leader in nephrology research

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Dr. Liu’s legacy is built on his impactful research and contributions to nephrology and kidney disease treatment. Through his role as a PhD supervisor, he mentors the next generation of medical researchers, ensuring the continued advancement of nephrology studies. His future research aims to further refine non-invasive diagnostic tools, improve treatment strategies for membranous nephropathy, and explore new biomarkers for kidney disease prognosis. His leadership in interdisciplinary kidney disease research will continue to drive medical advancements, reinforcing his status as a pioneer in nephrology.

PROFESSIONAL MEMBERSHIPS 👥

  • Shandong Research Hospital Association Outstanding Young Scholar Branch - Standing Committee Member
  • Shandong Medical Association Nephrology Branch - Member
  • Shandong Medical Association Blood Purification Branch - Member
  • Shandong Medical Doctor Association Nephrology Physician Branch - Member
  • Shandong Medical Doctor Association Multidisciplinary Innovation in Kidney Diseases Professional Committee - Member

RESEARCH AND INNOVATIONS 🔮

ONGOING AND COMPLETED RESEARCH PROJECTS:

  • Extensive work on serum biomarkers for idiopathic membranous nephropathy
  • Multicenter observational studies on kidney diseases
  • Research on thrombotic risk factors in nephrology

PUBLICATIONS AND CITATIONS:

  • Multiple high-impact journal articles published in indexed journals
  • Significant citation index in SCI, Scopus, and Web of Science

PATENTS AND INNOVATIONS:

  • Research contributing to the development of non-invasive diagnostic tools
  • Innovative approaches in renal disease treatment strategies

EDITORIAL AND CONSULTING ROLES:

  • Peer reviewer for leading nephrology and medical journals
  • Active consultant in nephrology research projects

AWARDS AND RECOGNITIONS 🏆

Dr. Liu has received multiple accolades, including:

  • Taishan Scholar Young Expert (2019, 2025)
  • Outstanding Young Scholar in medical research
  • Recognized for excellence in nephrology research and innovation

NOTABLE PUBLICATIONS📑

"Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy

  • Authors: Li, Z. , Chen, P. , Zhang, Y. , Liu, Y. , Zhao, N.
  • Journal: Renal Failure
  • Year: 2024

"Research progress on extracellular vesicles in the renal tubular injury of diabetic kidney disease

  • Authors: Li, S. , Zheng, S. , Li, J. , Ma, C. , Liu, Y.
  • Journal: Frontiers in Endocrinology
  • Year: 2023

"Research progress on exosomes in podocyte injury associated with diabetic kidney disease

  • Authors: Li, J. , Zheng, S. , Ma, C. , Li, W. , Liu, Y.
  • Journal: Frontiers in Endocrinology
  • Year: 2023

"Optimal Value for Serum Anti-PLA2R Antibody in Primary Membranous Nephropathy: A Multicenter Observational Study

  • Authors: Chen, J. , Jia, X. , Wei, X. , Wang, D. , Xu, D.
  • Journal: American Journal of Nephrology
  • Year: 2022

"Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD–MBD in maintenance hemodialysis patients

  • Authors: Jia, X.-Y. , Wei, K. , Chen, J. , Liang, L.-M. , Xu, D.-M.
  • Journal: Journal of Bone and Mineral Metabolism
  • Year: 2021

Lihua Wang | Inherited Kidney Diseases | Best Researcher Award

Mrs. Lihua Wang | Inherited Kidney Diseases | Best Researcher Award

The Second Hospital of Dalian Medical University | China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Lihua Wang began her academic journey in clinical medicine, obtaining a 5-year degree from Shandong Medical University in 2007. She furthered her education with a 3-year post-graduate program at Shanghai Jiao Tong University, graduating in 2010. Her key curriculums included a comprehensive array of medical sciences, such as Organic Chemistry, Medical Physics, Cell Biology, Anatomy, Histology and Embryology, Physiology, Biochemistry, Immunology, Microbiology, Pathology, Pathophysiology, Pharmacology, Medical Genetics, Diagnosis, Internal Medicine Science, Surgery Science, Obstetrics and Gynecology Science, Pediatrics Science, Neurology and Psychiatry, Dermatology, Radiation Science, Ophthalmology, Otolaryngology, and Chinese Traditional Medicine.

PROFESSIONAL ENDEAVORS

Lihua Wang's professional career began in November 2010 at The Second Hospital of Dalian Medical University in Liaoning Province, China. She served as a General Practitioner until 2014, treating clinical diseases with a blend of traditional Chinese and Western medicine. Her expertise covered a wide range of areas including Pediatrics, Internal Medicine, Rheumatism, and Immune System diseases.

From November 2014 to 2020, she was promoted to Attending Doctor at the same hospital. In November 2020, she advanced to the position of Assistant Director Physician, a role she continues to hold. With over 15 years of experience, she is particularly skilled in treating complex diseases with traditional Chinese medical science, such as various types of glomerulonephritis, acute kidney failure, and chronic kidney disease.

CONTRIBUTIONS AND RESEARCH FOCUS ON INHERITED KIDNEY DISEASES

Lihua Wang has made significant contributions to the field of nephrology through her research. Her notable publications include:

  1. "Dencichine Ameliorates Renal Injury by Improving Oxidative Stress, Apoptosis, and Fibrosis in Diabetic Rats" published in Life Science.
  2. "Construction of a Drug, miRNA, and Transcription Factor Regulatory Network in Membranous Nephropathy Based on Oxidative Stress-Related Genes" published in the Journal of Taibah University for Science.
  3. "Diagnosis of Membranous Nephropathy with Anti-GBM Glomerulonephritis: A Case Series Report" published in BMC Nephrology.

IMPACT AND INFLUENCE

Dr. Wang's research has significantly impacted the understanding and treatment of nephrological diseases. Her work on oxidative stress, apoptosis, and fibrosis in diabetic rats has provided valuable insights into renal injury amelioration. Additionally, her research on membranous nephropathy has led to the development of a comprehensive regulatory network involving drugs, miRNA, and transcription factors, furthering the understanding of this condition.

ACADEMIC CITES

Dr. Wang's work has been cited in various academic publications, reflecting the influence and relevance of her research in the medical community. Her findings have contributed to the broader body of knowledge in nephrology and related fields.

LEGACY AND FUTURE CONTRIBUTIONS

Lihua Wang's legacy is characterized by her dedication to blending traditional Chinese medicine with modern medical practices to address complex health issues. Her ongoing research and clinical work continue to push the boundaries of medical science, particularly in the treatment of kidney diseases. Looking forward, Dr. Wang aims to expand her research efforts, leveraging her lab platform to conduct innovative studies that will further contribute to the medical field.

PERSONAL ATTRIBUTES

Dr. Wang is passionate, self-confident, honest, dedicated, and hardworking. She thrives under pressure and is committed to continuous learning and innovation in her field. Her ability to work under pressure and her dedication to her profession are key attributes that have driven her success and will continue to do so in the future.

NOTABLE PUBLICATIONS

Dencichine ameliorates renal injury by improving oxidative stress, apoptosis and fibrosis in diabetic rats 2020(12)

Randomized Control Study on Hemoperfusion Combined with Hemodialysis versus Standard Hemodialysis: Effects on Middle-Molecular-Weight Toxins and Uremic Pruritus 2020(9)

Melatonin decreases GSDME mediated mesothelial cell pyroptosis and prevents peritoneal fibrosis and ultrafiltration failure 2024(1)

Diagnosis of membranous nephropathy with Anti-GBM glomerulonephritis: a case series report 2024